ArticleO&G open2025
Associations Between Periviable and Preterm Birth and Severe Maternal Morbidity and Mortality.
Article in O&G open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the risk of severe maternal morbidity (SMM) and mortality associated with periviable or preterm birth.
methodsThis population-based retrospective cohort study analyzed U.S. delivery hospitalizations between the fourth quarters of 2015 and 2021 by using the National Inpatient Sample database. The primary outcome was SMM and mortality risk by gestational age (20-25 weeks vs 26-36 weeks vs 37-42 weeks). Multivariable logistic regression analysis was used to assess SMM risk. Secondary outcomes included organ system-based SMM indicators and subgroup analyses by 3-week gestational age intervals (eg, 20-22 weeks, 23-25 weeks). Population attributable fraction (PAF) estimates were calculated to determine the proportion of SMM due to periviable and preterm birth.
resultsAmong an estimated 22,208,488 weighted births, 0.6% were periviable (20-25 weeks), 9.4% were preterm (26-36 weeks), and 90.0% were term (37-42 weeks). Severe maternal morbidity and mortality rates were highest in individuals with periviable births (4.5%, adjusted relative risk [aRR] 6.8 95% CI, 6.4-7.3, 98/100,000 delivery hospitalizations; and aRR 26.4, 95% CI, 16.7-41.9, respectively) and preterm births (2.9%, aRR 3.6, 95% CI, 3.5-3.7, 31/100,000 delivery hospitalizations; and aRR 8.7, 95% CI, 6.4-11.7, respectively) compared with term births (0.5%, 3/100,000 delivery hospitalizations). The elevated risk for SMM remained when limited to spontaneous live births in individuals without chronic comorbidities associated with iatrogenic preterm delivery (periviable: aRR 3.8, 95% CI, 3.3-4.5; preterm: aRR 1.8, 95% CI, 1.7-2.0). Individuals with periviable births had the highest risk of cardiovascular, renal, respiratory, sepsis, shock, and hemorrhagic SMM events, and those with preterm births had the highest risk of eclampsia. The PAF for SMM and maternal death was highest in individuals with preterm births (26.3%, 95% CI, 25.6-27.1; and 48.1%, 95% CI, 39.9-55.2, respectively).
conclusionPeriviable and preterm birth is associated with an increased risk of SMM and mortality, emphasizing the maternal health burden associated with early deliveries and the need for coordinated maternal-fetal risk-appropriate care.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.